Schmidt H - Search Results

1

High bad and bcl-xL gene expression and combined bad, bcl-xL, bax and bcl-2 mRNA levels: molecular predictors for survival of stage 2 soft tissue sarcoma patients.

Köhler T, Würl P, Meye A, Lautenschläger C, Bartel F, Borchert S, Bache M, Schmidt H, Holzhausen HJ, Taubert H. Köhler T, et al. Among authors: schmidt h. Anticancer Res. 2002 May-Jun;22(3):1553-9. Anticancer Res. 2002. PMID: 12168836

2

Growth reduction of a xenotransplanted human soft tissue sarcoma by MDM2 antisense therapy via implanted osmotic minipumps.

Würl P, Bartel F, Meye A, Kappler M, Bache M, Schmidt H, Schönfelder M, Taubert H. Würl P, et al. Among authors: schmidt h. Int J Oncol. 2002 May;20(5):1087-93. Int J Oncol. 2002. PMID: 11956608

3

Elevated expression level of survivin protein in soft-tissue sarcomas is a strong independent predictor of survival.

Kappler M, Kotzsch M, Bartel F, Füssel S, Lautenschläger C, Schmidt U, Würl P, Bache M, Schmidt H, Taubert H, Meye A. Kappler M, et al. Among authors: schmidt u, schmidt h. Clin Cancer Res. 2003 Mar;9(3):1098-104. Clin Cancer Res. 2003. PMID: 12631613

4

Reduced expression of hMSH2 protein is correlated to poor survival for soft tissue sarcoma patients.

Taubert HW, Bartel F, Kappler M, Schuster K, Meye A, Lautenschläger C, Thamm-Mücke B, Bache M, Schmidt H, Holzhausen HJ, Würl P. Taubert HW, et al. Among authors: schmidt h. Cancer. 2003 May 1;97(9):2273-8. doi: 10.1002/cncr.11326. Cancer. 2003. PMID: 12712483 Free article.

5

The p53 gene in soft tissue sarcomas: prognostic value of DNA sequencing versus immunohistochemistry.

Taubert H, Würl P, Bache M, Meye A, Berger D, Holzhausen HJ, Hinze R, Schmidt H, Rath FW. Taubert H, et al. Among authors: schmidt h. Anticancer Res. 1998 Jan-Feb;18(1A):183-7. Anticancer Res. 1998. PMID: 9568075

6

Clinical relevance of pRb and p53 co-overexpression in soft tissue sarcomas.

Würl P, Meye A, Lautenschläger C, Schmidt H, Bache M, Kalthoff H, Schönfelder M, Rath FW, Taubert H. Würl P, et al. Among authors: schmidt h. Cancer Lett. 1999 May 24;139(2):159-65. doi: 10.1016/s0304-3835(99)00034-8. Cancer Lett. 1999. PMID: 10395173

7

mdm2 mRNA level is a prognostic factor in soft tissue sarcoma.

Taubert H, Koehler T, Meye A, Bartel F, Lautenschläger C, Borchert S, Bache M, Schmidt H, Würl P. Taubert H, et al. Among authors: schmidt h. Mol Med. 2000 Jan;6(1):50-9. Mol Med. 2000. PMID: 10803408 Free PMC article.

8

A multifactorial prognostic model for adult soft tissue sarcoma considering clinical, histopathological and molecular data.

Würl P, Lautenschläger C, Meye A, Schmidt H, Bache M, Rath FW, Schönfelder M, Taubert H. Würl P, et al. Among authors: schmidt h. Anticancer Res. 2000 May-Jun;20(3B):2065-72. Anticancer Res. 2000. PMID: 10928153

9

Amplification of the MDM2 gene, but not expression of splice variants of MDM2 MRNA, is associated with prognosis in soft tissue sarcoma.

Bartel F, Meye A, Würl P, Kappler M, Bache M, Lautenschläger C, Grünbaum U, Schmidt H, Taubert H. Bartel F, et al. Among authors: schmidt h. Int J Cancer. 2001 May 20;95(3):168-75. doi: 10.1002/1097-0215(20010520)95:3<168::aid-ijc1029>3.0.co;2-a. Int J Cancer. 2001. PMID: 11307150

10

Transfection with mdm2-antisense or wtp53 results in radiosensitization and an increased apoptosis of a soft tissue sarcoma cell line.

Grünbaum U, Meye A, Bache M, Bartel F, Würl P, Schmidt H, Dunst J, Taubert H. Grünbaum U, et al. Among authors: schmidt h. Anticancer Res. 2001 May-Jun;21(3B):2065-71. Anticancer Res. 2001. PMID: 11497299

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,462 results

Search Page

Filters